Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waldman

Showing results (861-870 of 3,366) with videos related to

Pageof 337
Sort By:
Cancer Biology & Therapy|April 23, 2016
GUCY2C ligand replacement to prevent colorectal cancerErik S Blomain, Amanda M Pattison, Scott A Waldman
Medical Group Management|February 11, 1979
Supervisory training produces positive changes in self-confidence and job performanceT J DeHaan, G C Thornton, D A Waldman
American Journal of Ophthalmology|May 1, 1996
Cerebellar astrocytoma manifesting as isolated, comitant esotropia in childhoodJ W Simon, J B Waldman, K C Couture
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 27, 2006
Cholestasis induced by parabolan successfully treated with the molecular adsorbent recirculating systemJacek Sein Anand, Zygmunt Chodorowski, Adam Hajduk, et al.
Transplantation|May 15, 1997
Human cytomegalovirus does not induce human leukocyte antigen class II expression on arterial endothelial cellsD A Knight, W J Waldman, D D Sedmak
Journal of the Massachusetts Dental Society|September 25, 2009
Adults with special needs and proper dental careH Barry Waldman, S P Perlman, Debra A Cinotti
Retinal Cases & Brief Reports|June 3, 2017
A SERIES OF FIVE PATIENTS WITH FOVEAL HYPOPLASIA DEMONSTRATING GOOD VISUAL ACUITYIan D Kirchner, Corey W Waldman, Janet S Sunness
Clinical Nuclear Medicine|December 1, 1992
Comparison of nomogram- and ultrasound-determined renal depths for calculation of glomerular filtration rates in spinal cord injury patientsJ Waldman, B Eisenberg, H G Murata, et al.
Seminars in Nephrology|November 18, 2008
Viruses and kidney disease: beyond HIVMeryl Waldman, Vickie Marshall, Denise Whitby, et al.
Molecular Cancer Therapeutics|January 9, 2003
Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitorsJung-Sik Kim, Heather Crooks, Aaron Foxworth, et al.
Pageof 337

Showing results (861-870 of 3,366) with videos related to

Sort By:
Pageof 337
Cancer Biology & Therapy|April 23, 2016
GUCY2C ligand replacement to prevent colorectal cancerErik S Blomain, Amanda M Pattison, Scott A Waldman
Medical Group Management|February 11, 1979
Supervisory training produces positive changes in self-confidence and job performanceT J DeHaan, G C Thornton, D A Waldman
American Journal of Ophthalmology|May 1, 1996
Cerebellar astrocytoma manifesting as isolated, comitant esotropia in childhoodJ W Simon, J B Waldman, K C Couture
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 27, 2006
Cholestasis induced by parabolan successfully treated with the molecular adsorbent recirculating systemJacek Sein Anand, Zygmunt Chodorowski, Adam Hajduk, et al.
Transplantation|May 15, 1997
Human cytomegalovirus does not induce human leukocyte antigen class II expression on arterial endothelial cellsD A Knight, W J Waldman, D D Sedmak
Journal of the Massachusetts Dental Society|September 25, 2009
Adults with special needs and proper dental careH Barry Waldman, S P Perlman, Debra A Cinotti
Retinal Cases & Brief Reports|June 3, 2017
A SERIES OF FIVE PATIENTS WITH FOVEAL HYPOPLASIA DEMONSTRATING GOOD VISUAL ACUITYIan D Kirchner, Corey W Waldman, Janet S Sunness
Clinical Nuclear Medicine|December 1, 1992
Comparison of nomogram- and ultrasound-determined renal depths for calculation of glomerular filtration rates in spinal cord injury patientsJ Waldman, B Eisenberg, H G Murata, et al.
Seminars in Nephrology|November 18, 2008
Viruses and kidney disease: beyond HIVMeryl Waldman, Vickie Marshall, Denise Whitby, et al.
Molecular Cancer Therapeutics|January 9, 2003
Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitorsJung-Sik Kim, Heather Crooks, Aaron Foxworth, et al.
Pageof 337